Citation Impact
Citing Papers
Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin.
1983
Selective Formation of Covalent Protein Heterodimers with an Unnatural Amino Acid
2011
Engineering precision nanoparticles for drug delivery
2020 Standout
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
2009 StandoutNobel
Incorporation of novel 1-alkylcarbonyloxymethyl prodrugs of 5-fluorouracil into poly(lactide-co-glycolide) nanoparticles
2007
The implications of angiogenesis for the biology and therapy of cancer metastasis
1994 Standout
Analysis of an evolutionary species–area relationship
2000 Nature
Cancer Stem Cells
2006
The evolving role of natural products in drug discovery
2005 Standout
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Microbial–host interactions specifically control the glycosylation pattern in intestinal mouse mucosa
2002
Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
1989 Standout
cRGD‐Functionalized Polymer Micelles for Targeted Doxorubicin Delivery
2004
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Conjugation of phenyl isothiocyanate derivatives of carborane to antitumor antibody and in vivo localization of conjugates in nude mice
1991
Prodrug Strategies in Anticancer Chemotherapy
2007
Linker Technologies for Antibody–Drug Conjugates
2013
Cancer Statistics, 2006
2006 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma
2003
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
2005
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Potent antibody drug conjugates for cancer therapy
2009
Micellar Nanocarriers: Pharmaceutical Perspectives
2006
Monoclonal antibody drug immunoconjugates for targeted treatment of cancer
2003
Inflammatory Bowel Disease
1991 Standout
The Molecular Basis of Leukemia
2004
Environmentally responsive peptides as anticancer drug carriers☆
2009
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Antibody–drug conjugates: targeted drug delivery for cancer
2010
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Antibody-targeted chemotherapy with immunoconjugates of calicheamicin
2003
Self-assembled prodrugs: An enzymatically triggered drug-delivery platform
2008
Natural products and Pharma 2011: Strategic changes spur new opportunities
2011
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
Safety and efficacy of gemtuzumab ozogamicin in pediatric patients with advanced CD33+ acute myeloid leukemia
2005
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting
1998
Two-stage enzyme mediated drug release from LMWG hydrogels
2005 StandoutNobel
Protease-Activated Drug Development
2012
A Bioorthogonal Reaction of N‐Oxide and Boron Reagents
2015 StandoutNobel
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)
2002
Targeted polymeric micelles for delivery of poorly soluble drugs
2004
Antibody–cytotoxic agent conjugates for cancer therapy
2005
Folate Receptor-Mediated Drug Targeting: From Therapeutics to Diagnostics
2005
Antibody‐Drug Conjugates for the Treatment of Cancer
2012
Multifunctional polymeric micelles for delivery of drugs and siRNA
2014
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities
2003
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Antibody–Drug Conjugates: An Emerging Concept in Cancer Therapy
2014
Preservation of Fertility in Patients with Cancer
2009 Standout
Arming antibodies: prospects and challenges for immunoconjugates
2005
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence
2005
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
2003
Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity
2003
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
2004
Cancer Therapy with Radiolabeled and Drug/Toxin-conjugated Antibodies
2005
Human α1-proteinase inhibitor
1984 StandoutNobel
Composition of human colonic mucin. Selective alteration in inflammatory bowel disease.
1983
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Gut Microbiota in Health and Disease
2010 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Drug Discovery and Natural Products: End of an Era or an Endless Frontier?
2009 StandoutScience
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Acute Myeloid Leukemia
2015 Standout
Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting
2019
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Supramolecular hydrogels for enzymatically triggered self-immolative drug delivery
2010
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Design, Synthesis, and Biological Evaluation of Doxorubicin−Formaldehyde Conjugates Targeted to Breast Cancer Cells
2004
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
The effect of particle design on cellular internalization pathways
2008 Standout
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Functional π-Gelators and Their Applications
2014 Standout
Community Assembly Through Adaptive Radiation in Hawaiian Spiders
2004 StandoutScience
A Pictet-Spengler ligation for protein chemical modification
2012 StandoutNobel
Proteolysis: A Biological Process Adapted in Drug Delivery, Therapy, and Imaging
2009
Antibody therapy for acute myeloid leukaemia
2013
Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies
2003
Antibody-Targeted Chemotherapy with the Calicheamicin Conjugate hu3S193- N -Acetyl γ Calicheamicin Dimethyl Hydrazide Targets Lewisy and Eliminates Lewisy-Positive Human Carcinoma Cells and Xenografts
2004
Nucleotide sequences of immunoglobulin epsilon genes of chimpanzee and orangutan: DNA molecular clock and hominoid evolution.
1987 StandoutNobel
Antibody-Drug Conjugates in Cancer Therapy
2012
Aggregation Behavior of Poly(ethylene glycol-bl-propylene sulfide) Di- and Triblock Copolymers in Aqueous Solution
2009 StandoutNobel
Complete sequence of the cDNA for human .alpha.1-antitrypsin and the gene for the S variant
1984
Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug.
2002
Carboxy terminal fragment of human α-1-antitrypsin from hydroxylamine clevage: Homology with antithrombin III
1979
Natural product and natural product derived drugs in clinical trials
2014 Standout
The biology of cancer metastasis and implications for therapy
1987
In vivoDrug-Linker Stability of an Anti-CD30 Dipeptide-Linked Auristatin Immunoconjugate
2005
A multidrug resistance transporter from human MCF-7 breast cancer cells
1998 Standout
Mechanically Induced Gel Formation
2013 StandoutNobel
The Chemistry of Neutron Capture Therapy
1998 Standout
Cloning and sequence of cDNA coding for alpha 1-antitrypsin.
1981
Site-Specific Antibody–Drug Conjugates: The Nexus of Bioorthogonal Chemistry, Protein Engineering, and Drug Development
2014 StandoutNobel
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin
2004
Reduced graphene oxide field-effect transistor for label-free femtomolar protein detection
2012
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
2003
Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate.
2003
The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
1997
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
A cell nanoinjector based on carbon nanotubes
2007 StandoutNobel
Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates
2008
Rational Design and Synthesis of Androgen Receptor-Targeted Nonsteroidal Anti-Androgen Ligands for the Tumor-Specific Delivery of a Doxorubicin−Formaldehyde Conjugate
2003
25th Anniversary Article: The Evolution of Electronic Skin (E‐Skin): A Brief History, Design Considerations, and Recent Progress
2013 Standout
Works of Dan Shochat being referenced
Purification and Characterization of Carcinoembryonic Antigen from GW-39, a Xenografted Human Colonic Tumor System
1988
Studies on the structure of the organ-specific determinant of human colonic mucin☆
1989
Comparative immunological study of albumins of Anolis lizards of the Caribbean islands
1981
Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies.
2001
A Calicheamicin Conjugate with a Fully Humanized Anti-MUC1 Antibody Shows Potent Antitumor Effects in Breast and Ovarian Tumor Xenografts
2005
Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma
1996
N-Succinyl-(β-alanyl-l -leucyl-l -alanyl-l -leucyl)doxorubicin: An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity
2001
Colon-specific antigen-p (CSAp). II: Further characterization in colorectal and pancreatic cancer
1982
CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity.
2002
Protease digestion of colonic mucin. Evidence for the existence of two immunochemically distinct mucins.
1981
Gemtuzumab Ozogamicin, A Potent and Selective Anti-CD33 Antibody−Calicheamicin Conjugate for Treatment of Acute Myeloid Leukemia
2001
Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model.
1988
Primary structure of human alpha1-protease inhibitor. The complete amino acid sequence of cyanogen bromide fragment II
1978
Differential Expression of Tumor-Associated Antigens in Human Colon Carcinomas Xenografted Into Nude Mice<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>
1983